In the wake of the recent financial crisis, over-the-counter (OTC) derivatives have been blamed for increasing systemic risk. Although OTC derivatives were not a central cause of the crisis, the complexity and limited transparency of the market reinforced the potential for excessive risk-taking, as regulators did not have a clear view into how OTC derivatives were being used. We discuss how the New York Fed and other regulators could improve weaknesses in the OTC derivatives market through stronger oversight and better regulatory incentives for infrastructure improvements to reduce counterparty credit risk and bolster market liquidity, efficiency, and transparency. Used responsibly with these reforms, over-the-counter derivatives can provide important risk management and liquidity benefits to the financial system.

More on this topic

BFI Working Paper·Feb 20, 2025

Non est Disputandum de Generalizability? A Glimpse into The External Validity Trial

John List
Topics: Uncategorized
BFI Working Paper·Feb 18, 2025

How Costly Are Business Cycle Volatility and Inflation? A Vox Populi Approach

Dimitris Georgarakos, Kwang Hwan Kim, Olivier Coibion, Myungkyu Shim, Myunghwan Andrew Lee, Yuriy Gorodnichenko, Geoff Kenny, Seowoo Han, and Michael Weber
Topics: Uncategorized
BFI Working Paper·Feb 14, 2025

Decisions Under Risk are Decisions Under Complexity: Comment

Daniel Banki, Uri Simonsohn, Robert Walatka, and George Wu
Topics: Uncategorized